Search
Hainan Pharmaceutical Faces Uncertainty in Clinical Trial Outcomes for Innovative Drugs Pineabin and Flunifidone
1 week ago /
Read about 0 minute
Author：小编
On May 24, 2025, Hainan Pharmaceutical hosted a presentation for investors, showcasing the clinical status and unique attributes of its two innovative drugs, Pineabin and Flunifidone. The company acknowledged the lingering uncertainty surrounding the outcomes of forthcoming clinical trials for these medications and their potential approval by the National Medical Products Administration for market introduction. Hainan Pharmaceutical has pledged to provide timely updates on the progress of its innovative drug portfolio.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
